These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33283723)

  • 21. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma.
    Peng L; Liu YH; Nie S; Gao M
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8367-8376. PubMed ID: 32894543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
    Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
    Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p.
    Liu XF; Wang K; Du HC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7598-7611. PubMed ID: 32744686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA UCA1 regulates CCR7 expression to promote tongue squamous cell carcinoma progression by sponging miR-138-5p.
    Shi TT; Li R; Zhao L
    Neoplasma; 2020 Nov; 67(6):1256-1265. PubMed ID: 32749849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
    Wang P; Liu YH; Yao YL; Li Z; Li ZQ; Ma J; Xue YX
    Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA cancer susceptibility candidate 2 (CASC2) alleviates the high glucose-induced injury of CIHP-1 cells via regulating miR-9-5p/PPARγ axis in diabetes nephropathy.
    Li F; Dai B; Ni X
    Diabetol Metab Syndr; 2020; 12():68. PubMed ID: 32774472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA CASC2 restrains high glucose-induced proliferation, inflammation and fibrosis in human glomerular mesangial cells through mediating miR-135a-5p/TIMP3 axis and JNK signaling.
    Zhu D; Wu X; Xue Q
    Diabetol Metab Syndr; 2021 Aug; 13(1):89. PubMed ID: 34446088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis.
    Chi J; Liu T; Shi C; Luo H; Wu Z; Xiong B; Liu S; Zeng Y
    Biomed Pharmacother; 2019 Oct; 118():109201. PubMed ID: 31545227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA HCG11 enhances osteosarcoma phenotypes by sponging miR-1245b-5p that directly inhibits plakophilin 2.
    Yan H; Zhou Y; Chen Z; Yan X; Zhu L
    Bioengineered; 2022 Jan; 13(1):140-154. PubMed ID: 34949159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
    Lu T; Wang R; Cai H; Cui Y
    Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
    Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
    BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA CASC2 targets CAV1 by competitively binding with microRNA-194-5p to inhibit neonatal lung injury.
    Ji L; Liu Z; Dong C; Wu D; Yang S; Wu L
    Exp Mol Pathol; 2021 Feb; 118():104575. PubMed ID: 33212124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
    Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
    Xu DF; Wang LS; Zhou JH
    Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA CASC2 Alleviates the Progression of Diabetic Nephropathy by Regulating the miR-144/SOCS2 Signalling Axis.
    Min XQ; Xie Y
    Kidney Blood Press Res; 2020; 45(6):837-849. PubMed ID: 33227790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. lncRNA CASC2 Enhances
    Tao L; Tian P; Yang L; Guo X
    Biomed Res Int; 2020; 2020():7183629. PubMed ID: 33134385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.